소개

이 페이지에서는 Thomas Gad의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

가장 높은 순위의 내부자를 확인하세요
내부자 포지션이 보고된 기업

SEC 서류에 따르면 Thomas Gad 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:YMAB / Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director 0
차트 해석 방법

아래 차트는 Thomas Gad에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Thomas Gad의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)		 지분
가치		 거래
가치		 잔여
가치
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		U - Other -60,000 0 -100.00 8.60 -516,000
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		U - Other -67,681 0 -100.00 8.60 -582,057
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		D - Sale to Issuer -60,235 0 -100.00
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		U - Other -245,486 0 -100.00 8.60 -2,111,180
2025-06-05 2025-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 103,000 305,721 50.81 2.00 206,000 611,442
2025-03-11 2025-03-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -10,810 202,721 -5.06 5.23 -56,536 1,060,231
2025-01-22 2025-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		A - Award 32,000 213,531 17.63
2024-09-20 2024-09-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 22,831 181,531 14.39 4.38 100,000 795,106
2024-09-17 2024-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -30,000 67,681 -30.71 12.97 -389,100 877,823
2024-09-17 2024-09-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -65,000 97,681 -39.96 13.47 -875,550 1,315,763
2024-06-11 2024-06-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -35,000 162,681 -17.71 12.00 -420,000 1,952,172
2024-06-11 2024-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -35,000 197,681 -15.04 12.03 -421,050 2,378,102
2024-05-23 2024-05-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -7,351 232,681 -3.06 13.00 -95,563 3,024,853
2024-05-23 2024-05-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -25,000 240,032 -9.43 12.00 -300,000 2,880,384
2024-03-07 2024-03-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -3,900 158,700 -2.40 16.44 -64,116 2,609,028
2024-01-22 2024-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		A - Award 22,100 162,600 15.73
2023-12-26 2023-12-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 140,500 55.25 2.00 100,000 281,000
2023-12-15 2023-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 265,032 -15.87 6.61 -330,500 1,751,862
2023-12-15 2023-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 315,032 -13.70 6.83 -341,500 2,151,669
2023-12-15 2023-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 365,032 -12.05 6.58 -329,000 2,401,911
2023-11-22 2023-11-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -75,000 415,032 -15.31 5.31 -397,988 2,202,367
2023-11-22 2023-11-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -75,000 490,032 -13.27 5.30 -397,395 2,596,484
2023-01-19 2023-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		A - Award 40,500 90,500 81.00
2022-05-19 2022-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 60,000 60,000
2022-02-09 2022-02-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -64,276 565,032 -10.21 6.96 -447,117 3,930,476
2022-02-09 2022-02-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -125,863 629,308 -16.67 7.01 -882,891 4,414,407
2022-02-09 2022-02-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -91,031 755,171 -10.76 7.59 -691,180 5,733,862
2022-02-07 2022-02-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -101,104 846,202 -10.67 7.70 -778,531 6,516,009
2022-02-07 2022-02-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -35,060 947,306 -3.57 7.90 -277,027 7,485,138
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -8,000 153,000 -4.97
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -8,000 50,000 -13.79 10.15 -81,161 507,255
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -55,783 982,366 -5.37 10.96 -611,281 10,764,963
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -32,272 1,038,149 -3.01 10.07 -325,131 10,459,040
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -20,184 1,070,421 -1.85 11.35 -229,103 12,150,028
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,134 1,090,605 -4.39 10.51 -526,713 11,458,005
2022-01-24 2022-01-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -112,767 1,140,739 -9.00 11.33 -1,277,289 12,920,923
2022-01-20 2022-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -69,414 1,253,506 -5.25 10.89 -756,092 13,653,814
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -8,000 161,000 -4.73
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -400 1,322,920 -0.03 11.46 -4,584 15,160,663
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -8,000 50,000 -13.79 11.54 -92,314 576,965
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 110,000 110,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		G - Gift 60,000 1,383,320 4.53
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		G - Gift -60,000 1,323,320 -4.34
2021-12-08 2021-12-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -10,000 1,383,320 -0.72 17.58 -175,832 24,323,192
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -4,000 1,393,320 -0.29 16.50 -65,982 22,983,510
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -40,000 1,397,320 -2.78 16.48 -659,260 23,029,930
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,437,320 -0.28 16.98 -67,912 24,402,963
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -7,770 1,441,320 -0.54 17.04 -132,433 24,566,002
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -12,800 1,449,090 -0.88 17.11 -218,947 24,786,974
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -600 1,461,890 -0.04 16.94 -10,166 24,769,241
2021-12-01 2021-11-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -22,437 1,462,490 -1.51 17.16 -385,026 25,096,767
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 169,000 -22.83
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 50,000 -50.00 17.06 -852,850 852,850
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 100,000 100.00 2.00 100,000 200,000
2021-11-18 2021-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,484,927 -0.27 19.33 -77,302 28,696,957
2021-11-01 2021-10-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,488,927 -0.27 24.82 -99,261 36,948,021
2021-10-19 2021-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,492,927 -0.27 27.20 -108,799 40,607,316
2021-10-04 2021-09-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,496,927 -0.27 28.26 -113,054 42,308,546
2021-09-17 2021-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,500,927 -0.27 33.64 -134,579 50,498,239
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 219,000 -18.59
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 50,000 2.00 100,000 100,000
2021-09-07 2021-09-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 1,504,927 -3.22 33.18 -1,658,915 49,930,919
2021-08-17 2021-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -1,779 1,554,927 -0.11 28.96 -51,527 45,036,906
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -22,111 1,556,706 -1.40 29.33 -648,527 45,658,965
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,578,817 -0.25 29.14 -116,544 46,000,412
2021-08-17 2021-08-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -1,110 1,582,817 -0.07 31.01 -34,426 49,089,645
2021-08-05 2021-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,583,927 -0.25 33.73 -134,927 53,428,709
2021-07-21 2021-07-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,587,927 -0.25 32.47 -129,875 51,558,084
2021-07-08 2021-07-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,591,927 -0.25 31.87 -127,465 50,728,664
2021-07-02 2021-06-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,595,927 -0.25 33.86 -135,446 54,040,323
2021-06-15 2021-06-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,599,927 -0.25 35.80 -143,217 57,284,266
2021-06-01 2021-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,603,927 -0.25 36.95 -147,813 59,270,396
2021-05-20 2021-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,607,927 -0.25 34.07 -136,290 54,785,932
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 269,000 -2.54
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 27.96 -195,730
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 276,000 -2.47
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,611,927 -0.25 26.60 -106,388 42,872,422
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 26.61 -186,253
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -9,000 283,000 -3.08
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 1,615,927 -0.37 30.27 -181,615 48,912,818
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -9,000 0 -100.00 30.26 -272,331
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 292,000 -2.34
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,621,927 -0.25 36.78 -147,102 59,647,176
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 36.79 -257,554
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-03-12 2021-03-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		J - Other 1,029,927 1,625,927 172.81
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -9,000 299,000 -2.92
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 596,000 -1.00 35.50 -213,029 21,160,861
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -9,000 0 -100.00 35.51 -319,611
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 308,000 -2.22
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 602,000 -0.66 47.09 -188,367 28,349,203
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 47.08 -329,556
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 315,000 -2.17
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 606,000 -0.66 41.97 -167,888 25,435,032
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 41.99 -293,897
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 322,000 -2.13
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 610,000 -0.65 46.56 -186,230 28,400,136
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 46.51 -325,563
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 329,000 -2.08
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 614,000 -0.65 49.31 -197,248 30,277,568
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 49.36 -345,509
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 336,000 -2.04
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 51.98 -363,833
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 343,000 -2.00
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 53.01 -371,065
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-16 2020-12-14 4 VYMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 618,000 -0.64 52.89 -211,546 32,683,795
2020-12-16 2020-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 91,450 91,450
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 0 -100.00 51.17 -2,558,640
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 0 -100.00 50.75 -2,537,620
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-02 2020-12-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 622,000 -0.64 51.42 -205,685 31,984,049
2020-11-17 2020-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 626,000 -0.63 46.17 -184,672 28,901,105
2020-11-05 2020-11-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 630,000 -0.63 43.69 -174,769 27,526,086
2020-10-19 2020-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 634,000 -0.63 39.15 -156,604 24,821,671
2020-10-02 2020-10-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 638,000 -0.62 38.88 -155,524 24,806,142
2020-09-17 2020-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 642,000 -0.62 40.81 -163,225 26,197,580
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -22,569 450,000 -4.78
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -22,569 0 -100.00 41.00 -925,426
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 22,569 22,569 2.00 45,138 45,138
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -13,571 472,569 -2.79
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -13,571 0 -100.00 40.33 -547,331
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 13,571 13,571 2.00 27,142 27,142
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -13,860 486,140 -2.77
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -13,860 0 -100.00 41.58 -576,360
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 13,860 13,860 2.00 27,720 27,720
2020-09-02 2020-09-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 646,000 -0.62 41.60 -166,390 26,872,050
2020-08-19 2020-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 650,000 -0.61 40.35 -161,392 26,226,200
2020-08-13 2020-08-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -13,000 654,000 -1.95 39.51 -513,636 25,839,867
2020-08-13 2020-08-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -37,000 667,000 -5.26 40.06 -1,482,042 26,716,818
2020-08-05 2020-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 704,000 -0.56 36.51 -146,026 25,700,576
2020-07-17 2020-07-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 708,000 -0.56 40.06 -160,229 28,360,568
2020-07-06 2020-07-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 712,000 -0.56 42.04 -168,178 29,935,684
2020-06-16 2020-06-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 716,000 -0.56 43.45 -173,811 31,112,205
2020-06-05 2020-06-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 720,000 -0.55 41.61 -166,444 29,959,848
2020-05-29 2020-05-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 724,000 -6.46 39.01 -1,950,460 28,242,661
2020-05-20 2020-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 774,000 -0.51 39.65 -158,596 30,688,326
2020-05-14 2020-05-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 778,000 -6.04 39.04 -1,951,935 30,372,109
2020-05-05 2020-05-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 828,000 -0.48 32.35 -129,404 26,786,711
2020-04-15 2020-04-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 832,000 -0.48 29.43 -117,711 24,483,930
2020-03-18 2020-03-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 836,000 -0.48 18.01 -72,041 15,056,527
2020-03-04 2020-03-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 840,000 -0.47 29.18 -116,713 24,509,772
2020-02-20 2020-02-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 844,000 -0.47 32.78 -131,133 27,669,021
2020-02-11 2020-02-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 848,000 -0.47 33.03 -132,121 28,009,610
2020-01-29 2020-01-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 852,000 -0.47 35.06 -140,224 29,867,627
2020-01-15 2020-01-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 856,000 -0.47 30.90 -123,612 26,452,968
2020-01-09 2020-01-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 130,000 130,000
2019-12-31 2019-12-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		J - Other -201 1,030,356 -0.02
2019-12-17 2019-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 860,000 -0.46 31.54 -126,176 27,127,926
2019-12-17 2019-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		G - Gift -8,000 864,000 -0.92
2019-12-04 2019-12-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 872,000 -0.46 32.48 -129,930 28,324,827
2019-11-19 2019-11-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 876,000 -0.45 28.41 -113,658 24,891,014
2019-11-05 2019-11-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 880,000 -0.45 30.10 -120,418 26,491,960
2019-10-22 2019-10-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 884,000 -0.45 27.59 -110,351 24,387,527
2019-10-08 2019-10-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 888,000 -0.45 25.21 -100,848 22,388,256
2019-09-17 2019-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 892,000 -0.45 30.59 -122,376 27,289,759
2019-09-05 2019-09-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 896,000 -0.44 25.77 -103,081 23,090,099
2019-08-20 2019-08-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 900,000 -0.44 27.70 -110,805 24,931,080
2019-08-06 2019-08-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 904,000 -0.44 21.78 -87,106 19,685,866
2019-07-23 2019-07-22 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 908,000 -0.44 22.54 -90,177 20,470,134
2019-07-10 2019-07-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 912,000 -0.44 22.40 -89,592 20,426,885
2019-06-25 2019-06-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 916,000 -0.43 21.77 -87,098 19,945,350
2019-06-11 2019-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 920,000 -0.43 22.79 -91,166 20,968,272
2019-06-04 2019-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 924,000 -0.43 20.03 -80,121 18,507,997
2019-05-29 2019-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 928,000 -0.64 20.21 -121,252 18,753,674
2019-05-14 2019-05-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 934,000 -0.64 20.61 -123,647 19,247,779
2019-04-11 2019-04-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -150,000 940,000 -13.76 25.80 -3,870,000 24,252,000
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -800 1,090,000 -0.07 26.93 -21,545 29,355,444
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -99,200 1,090,800 -8.34 26.02 -2,581,184 28,382,616
2018-12-13 2018-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 107,500 107,500
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,251,114
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)